InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,634.80
(
0.80%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
86.84
(
-0.09%
)
Bitcoin
60,387.43
(
0.37%
)

Replies to post #1899 on Rexahn Pharmaceuticals, Inc. (REXN)

Replies to #1899 on Rexahn Pharmaceuticals, Inc. (REXN)

bioresearcher

01/31/14 8:01 PM

#1900 RE: freshy #1899

NEWS SOON: "Supinoxin™ Phase I clinical trial enters third dosing group; preliminary data expected in the first quarter of 2014"

cooljet

01/31/14 10:59 PM

#1903 RE: freshy #1899

yes.....thanks for the correction.....I meant 1.22